Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis is a research paper published in Journal of Translational Autoimmunity (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: AI161022
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: 85160
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: / NIAMS AR076758
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: AR072623
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: AR049192
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: AR074992
NIAMS NIH HHS
Grant: R01 AR076758
NIAMS NIH HHS
Grant: P30 AR074992
National Institutes of Health
Grant: 5R01AR049192-09
Regulatory Mechanisms of Implant-Induced Osteolysis
National Institutes of Health
Grant: 5R01AR072623-04
Mechanisms of Physiologic and Pathologic Osteoclastogenesis
National Institutes of Health
Grant: 5R01AI161022-04
Differential Inflammasome Regulation in the pathogenesis of S. aureus osteomyelitis
National Institutes of Health
Grant: 1R01AR076758-01
Role of gasdermin D in bone resorption
National Institutes of Health
Grant: 1P30AR074992-01
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)
NIAID
National Institutes of Health
Shriners Hospitals for Children
FWCI
1.25
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals